| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |